Literature DB >> 26478535

Excision Versus Ablation in Renal Cancer: Optimising Outcome and Minimising Risk.

Matthew C Hayes1, David J Breen2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26478535     DOI: 10.1016/j.eururo.2015.10.004

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  FMNL1 Exhibits Pro-Metastatic Activity via CXCR2 in Clear Cell Renal Cell Carcinoma.

Authors:  Mei-Fang Zhang; Qiu-Li Li; Yu-Feng Yang; Yun Cao; Chris Zhiyi Zhang
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

Review 2.  The past, present, and future of urological quality improvement collaboratives.

Authors:  Adam C Reese; Serge Ginzburg
Journal:  Transl Androl Urol       Date:  2021-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.